Toggle Main Menu Toggle Search

ePrints

Bak: A Downstream Mediator of Fenretinide-Induced Apoptosis of SH-SY5Y Neuroblastoma Cells

Lookup NU author(s): Professor Penny Lovat, Bojidar Goranov, Dr Chris Redfern

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Unlike 13-cis-retinoic acid, the synthetic retinoid fenretinide [N-(4-hydroxyphenyl)retinamide] induces apoptosis of neuroblastoma cells by mechanisms involving retinoic acid receptors and oxidative stress. After screening a cDNA array for apoptosis-related genes, the Bcl2-related protein Bak was identified as a fenretinide-inducible gene in SH-SY5Y neuroblastoma cells, and this was confirmed by Western blotting and flow cytometry. Although fenretinide acts synergistically in vitro with chemotherapeutic drugs, these drugs did not induce Bak expression. Retinoic acid receptor antagonists did not block the induction of Bak by fenretinide. Conversely, Bak induction was blocked by the antioxidant vitamin C. Overexpression of Bak increased apoptosis in both the presence and absence of fenretinide, whereas expression of antisense Bak inhibited fenretinide-induced apoptosis. Bak expression was also induced in cells overexpressing the stress-induced transcription factor GADD153, but Bak expression was inhibited in cells expressing an antisense GADD153 construct. These results suggest that Bak is a downstream mediator of an oxidative stress pathway leading to apoptosis of SH-SY5Y neuroblastoma cells in response to fenretinide.


Publication metadata

Author(s): Lovat, P.E., Oliverio, S, Corazzari, M., Rodolfo, C., Ranalli, M., Goranov, B., Melino, G., Redfern,C.P.F., Piacentini, M.

Publication type: Article

Publication status: Published

Journal: Cancer Research

Year: 2003

Volume: 63

Issue: 21

Pages: 7310-7313

Print publication date: 01/11/2003

ISSN (print): 0008-5472

ISSN (electronic): 1538-7445

PubMed id: 14612528


Actions

    Link to this publication


Share